Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06453538
Other study ID # 27 /1801/2022
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 1, 2023
Est. completion date December 30, 2025

Study information

Verified date June 2024
Source Turku University Hospital
Contact Marjo Ajosenpää, MD
Phone +35823133247
Email marjo.ajosenpaa@varha.fi
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To this study is recruiting non- emergency patients to whom are planning to make coronary artery bypass intervention. From all patients are going to examine transthoracic echo, collect blood samples and register overnight sleep polygraph in a qualified sleep laboratory two times; first before cabg and second one after surgery.


Description:

Detailed Description: Hypothesis, that sleep related apneas are increasing after coronary artery bypass surgery and sleep quality may deteriorate. We are trying to find out reasons which are leading to these problems which are caused by microemboli in the brain from using heart lung machine, brain infarction caused by major surgery, thorax tissue trauma after operation or complications under perioperative treatment. Hypothesis is that if a patient is diagnosed with sleep apnea before cabg surgery, are postoperative results connected with postoperative outcomes and recovery. Sleep polygraph is made before surgery and approximately six months after surgery and transthoracic echo and laboratory tests. If connection between sleep quality and coronary bypass surgery can be made, findings can be used in clinical practice. Total amount of heart lung machine treated patients is waited to be 70. Off pump patient sample size is remarkably smaller so data is collected and compared with main sample population. Operation technique is decided when patient is scheduled to operation. Emergency patients are excluded, because pre- operative researches cannot be performed. Coronary artery disease is causing recruiting challenges, because patients often need urgent care. Other exclusion criteria are night time cpap- treatment and other heart operations (for example valvesurgery) during cabg. From all of the patients are collected basic information including age, weight, heigh, diseases, medication and medical history. Ekg is registered before and after surgery and sinus or other heart rhythms are recorded. Sleep polygraph six months postoperatively, when the patient is fully recovered from surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 54
Est. completion date December 30, 2025
Est. primary completion date December 30, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: Elective coronary artery bypass surgery Exclusion Criteria: - Emergency cabg - Night time cpap- treatment - other heart operations (for example valve surgery)

Study Design


Locations

Country Name City State
Finland Turku University Hospital Turku

Sponsors (1)

Lead Sponsor Collaborator
Turku University Hospital

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Other New York Heart Association -classification (NYHA) status Class I - No symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.
Class II - Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.
Class III - Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m).Comfortable only at rest.
Class IV - Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients
Before operation
Primary Incidence of sleep disorders before coronary artery bypass surgery (CABG), polysomnography Apnea-hypopnea index (AHI). Number of apneas and hypopneas that occur per hour of sleep. According to the American Academy of Sleep Medicine (AASM) it is categorized into mild (5-15 events/hour), moderate (15-30 events/hr), and severe (> 30 events/hr) (1). Before operation, as soon as operation has scheduled
Primary Sleep quality before CABG ESS, EPWORTH SLEEPINESS SCALE. All scores on the Epworth Sleepiness Scale fall between 0 and 24. Scores from 0 to 10 reflect normal levels of daytime sleepiness, and scores over 10 are considered to reflect excessive daytime sleepiness. Before operation, as soon as operation has scheduled
Primary A transthoracic echocardiogram Left ventricular end-diastolic diameter (LVEDD), Left ventricular end-systolic diameter (LVESD), Septal wall thickness (SWT), and Posterior wall thickness (PWT), Max/Min Diameter of IVC; all will be reported in cm. Before operation, as soon as operation has scheduled
Secondary Incidence of sleep disorders after coronary artery bypass surgery, polysomnography Apnea-hypopnea index (AHI). Number of apneas and hypopneas that occur per hour of sleep. According to the American Academy of Sleep Medicine (AASM) it is categorized into mild (5-15 events/hour), moderate (15-30 events/hr), and severe (> 30 events/hr) (1). After 6 to 8 months after surgery
Secondary Sleep quality after CABG ESS, EPWORTH SLEEPINESS SCALE. All scores on the Epworth Sleepiness Scale fall between 0 and 24. Scores from 0 to 10 reflect normal levels of daytime sleepiness, and scores over 10 are considered to reflect excessive daytime sleepiness After 6 to 8 months after surgery
Secondary A transthoracic echocardiogram Left ventricular end-diastolic diameter (LVEDD), Left ventricular end-systolic diameter (LVESD), Septal wall thickness (SWT), and Posterior wall thickness (PWT), Max/Min Diameter of IVC; all will be reported in cm. After operation, 3-5 months after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A